The Clatterbridge Cancer Centre NHS Foundation Trust requires a Radiopharmaceuticals Service Solution to support Nuclear Medicine, PET-CT and associated diagnostic and therapeutic services. The service must include: o Provision of a fully established cyclotron based radiopharmacy for production of labelled radioisotopes relevant for cancer diagnostics and therapy. o Provision of a generator or cyclotron based Tc-99m radiopharmacy service. o Provision of a radiopharmacy service capable of providing Lu-177 radiopharmaceuticals. The service may include: • Supply of licensed radiopharmaceuticals • PET radiotracers • Generators and associated consumables • Radiopharmacy support services • Quality assurance and regulatory compliance support • Logistics and delivery arrangements • Waste management and disposal • Equipment maintenance where applicable • Future expansion to support emerging treatments The Trust are seeking expressions of interest and supplier feedback to inform the requirements of these services. At this stage, anticipated contract dates are estimated only and to be confirmed as the procurement progresses.

Procurement Act 2023

Please express your interest in this pre-market engagement by confirming your interest and emailing Emma Seed [email protected]. Following expression of interest, we will issue a questionnaire for completion and provide further details regarding the engagement session, which may either be on MS Teams, or on-site. Deadline for expressions of interest is 10th November 2026.